AXALAP: Phase Ib study of AXAtilimab in Combination with OLAParib in BRCA1/2 and PALB2-associated metastatic HER2-negative breast cancer

Poster Presentation | May 30, 2025

Author

Lynce F, et al.

Congress

American Society of Clinical Oncology Annual Meeting

Chicago, Illinois | May 30 – June 3, 2025